Allurion BG

Success Stories

Allurion Patient

Trusted by over 

 

150,000

 

Patients around the world

As with any medical solution, results may vary from patient to patient, and some individuals may not respond to the treatment. Please consult a doctor to assess the risks and benefits before making your decision.

BMI Calculator

Results from the largest published study on the Allurion Balloon

A prospective study conducted on 1,770 overweight or obese patients (with an average Body Mass Index of 34.4 ± 5.3 kg/m²) across 19 international obesity centres demonstrated the following results1.
As with any medical solution, results may vary from patient to patient, and some individuals may not respond to the treatment. Please consult a doctor to assess the risks and benefits before making your decision.

ALU_Icon_WeightLossResults_white.png
Weight Loss


Average weight loss: 13.5 ± 5.8 kg
Percentage of total weight loss: 14.2 ± 5.0%

icon
BMI Reduction


Average reduction in Body Mass Index (BMI): 4.9 ± 2.0 points

ALU_Icon_SafeEffective_white.png
Rare Side Effects


3.95% of patients experienced side effects such as nausea, vomiting, and abdominal pain, while 0.34% had serious adverse events such as small bowel obstruction, pancreatitis, or gastric outlet obstruction.

qualité du Ballon Allurion

The Allurion Balloon is a regulated health product that bears the CE marking in accordance with this regulation.

To learn more about the Allurion Balloon, assess the risks and benefits of this solution, read the important safety information, and discuss it with your doctor.

Learn more
References

*Results may vary from one patient to another. The average of 14.2% (+/- 5%) was demonstrated by a clinical study conducted on 1,770 patients with an average BMI of 34.4 ± 5.3 kg/m² (1).

**The removal of the Allurion Balloon may, in very rare cases, require an endoscopic or surgical procedure. In rare cases, instead of being passed through the digestive tract, the deflated balloon may be expelled by vomiting.

***Eligibility for the placement of an Allurion Balloon will be assessed by a certified doctor after an initial consultation and a thorough review of your medical history. In the case of an extended Allurion Programme, your eligibility will be reassessed before each placement to ensure that you continue to meet the required conditions.

1. R. Ienca et al. The procedureless Elipse gastric balloon program: Multicenter experience in 1,770 consecutive patients. Obes Surg. 2020;30(9):3354-3362.
A multicentre, prospective, non-randomised, open registry study conducted on overweight or obese patients from January 2016 to June 2019 across 19 international obesity centres participating in the study. A total of 1,770 patients with an average BMI of 34.4 ± 5.3 kg/m² at baseline underwent treatment with the Elipse swallowable gastric balloon, with monthly visits and a total follow-up of 4 months. 63 patients (3.6%) did not complete the programme, and the balloon was removed before 4 months due to intolerance or other adverse effects.

2. World Health Organization - Key facts about obesity and overweight (who.int).

3. Best practice guidelines report "Overweight and obesity in adults: first-line medical management" from the Haute Autorité de Santé – September 2011.

4. This information is extracted from the device's leaflet - Instructions for use - Allurion Gastric Balloon - CS137-02-ENG-ART. If you have any further questions regarding this document, please consult your doctor.

Important information to consider before the placement of an Allurion Gastric Balloon

  • The Allurion Gastric Balloon is part of a behaviour modification programme that lasts for a minimum of 6 months, to which you must be fully committed. This device is designed to promote weight loss, but only by committing to changing your eating habits and increasing your physical activity will you be able to achieve and maintain a healthy weight in the long term.
  • It is important to note that the Allurion Gastric Balloon may cause adverse events, some of which may require removal by endoscopy. Rare cases of spontaneous hyperinflation, small intestine obstruction, stomach dilation, oesophagitis, pancreatitis, or stomach perforation have been reported, requiring surgical intervention.1,4 Please consult the full list of potential complications available on the page Important Safety Information.
  • The Allurion Gastric Balloon is not suitable for all patients. Pregnant individuals or those with a history of oesophageal or stomach surgery, among others, are not eligible for the procedure. The complete list of contraindications can be found in the device's instructions for use provided to doctors. Your doctor will review your medical history and conduct a physical examination to confirm your eligibility for the Allurion Programme.
  • It is crucial that each doctor and patient carefully assess the risks and benefits of the treatment before using the Allurion device. To learn more about the Allurion Balloon, its effectiveness, and its tolerability, discuss it with your doctor.
  • You must be available for follow-up with your doctor throughout the treatment period, especially if you experience the following symptoms, including but not limited to: persistent nausea, vomiting, dehydration, and/or abdominal pain. If you consult other healthcare professionals, inform them that an intragastric balloon is present. We encourage you to stay close to modern emergency care facilities during the time the balloon is in place, in case serious complications arise.